Research PapersAltered Drug Membrane Permeability in a Multidrug-Resistant Leishmania tropica Line
Section snippets
Drugs and Chemicals
DNM and doxorubicin hydrochloride were purchased from Farmitalia Carlo Erba. Vinblastine was obtained from Lilly S.A. Puromycin was from Sigma Chemical Co. Glutathione Sepharose 4B, Protein A Sepharose CL-4B and CNBr-activated Sepharose 4B were purchased from Pharmacia LKB Biotechnology. All other reagents were of standard laboratory grade.
Parasite Culture and Selection of DNM Resistant Line
L. tropica LRC-L39 was obtained from Dr. L. F. Schnur (Kuvin Center for the Study of Infectious and Tropical Diseases, Jerusalem, Israel). The WT line used
Characterization of the MDR Phenotype in a L. tropica Line
The L. tropica DNM-R150 line was generated in vitro using a stepwise selection process initiated with a concentration of 25 μM DNM. The time required to induce resistance at the maximum concentration of 150 μM DNM was approximately 5 months. The resistance index at the maximum DNM concentration was 62.3-fold (Table 1). In Rv1, Rv3 and Rv6 parasites, the ic50 values for DNM reverted to those for WT, ranging from 10 μM in the Rv1 (Table 1) to 6 μM in the Rv3 and 3 μM in the Rv6 line. These
Discussion
A main objective in this work has been to study whether modifications other than overexpression of a Pgp can contribute to the resistant phenotype in an L. tropica line resistant to DNM. The line shows an MDR-like phenotype similar to that described in mammalian cells. It is characterized by the amplification of the ltrmdr1 gene as an extrachromosomal element (DN circle) and the overexpression of a Pgp of 150 kDa. The resistance of parasites to DNM is unstable without drug pressure, as
Acknowledgements
The authors thank Dr. Ulisses Gazos (Federal University of Rio de Janeiro, Brazil) for the generous gift of the pLa06 probe and Dr. Antonio González (Instituto de Parasitologı́a y Biomedicina “Lopez-Neyra”, CSIC, Granada, Spain) for the β-tubulin gene from T. cruzi. We also thank Dr. Gregory Schneider (School of Medicine, St. Louis University, MO, USA) for revision and critical reading of the manuscript and Pharmacia Farmitalia (Barcelona, Spain) for the daunomycin used in this study. This work
References (42)
- et al.
The gene encoding vacuolar H+-ATPase subunit C is overexpressed in multidrug-resistant HL60 cells
Biochem Biophys Res Commun
(1992) - et al.
The role of passive transbilayer drug movement in multidrug resistance and its modulation
J Biol Chem
(1996) - et al.
Rapid kinetics of the interaction between daunomycin and drug-sensitive or drug-resistant P388 leukemia cells
FEBS Lett
(1992) - et al.
Biochemistry and regulation of folate and methotrexate transport in Leishmania major
J Biol Chem
(1987) - et al.
Methotrexate-resistant Leishmania donovani genetically deficient in the folate-methotrexate transporter
J Biol Chem
(1988) - et al.
Mechanisms of drug resistance in Leishmania
Parasitol Today
(1993) - et al.
Emetine-resistant mutants of Entamoeba histolytica overexpress mRNAs for multidrug resistance
Mol Biochem Parasitol
(1990) - et al.
Cloning and functional analysis of an extrachromosomally amplified multidrug resistance-like gene in Leishmania enriettii
Mol Biochem Parasitol
(1993) - et al.
Detection and characterization of Leishmania species and strains from mammals and vectors by hybridization and restriction endonuclease digestion of kinetoplast DNA
Veter Parasitol
(1986) - et al.
P-glycoprotein overexpression in methotrexate-resistant Leishmania tropica
Biochem Pharmacol
(1994)
Multidrug resistance and conservative amplification of the H region in Leishmania major
J Biol Chem
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Anal Biochem
A rapid alkaline extraction method for the isolation of plasmid DNA
Methods Enzymol
Protein measurement with the folin phenol reagent
J Biol Chem
Increased P-type ATPase activity in Leishmania tropica resistant to methotrexate
Biochem Biophys Res Commun
Increased mdr-1/P-glycoprotein expression after treatment of human colon carcinoma cells with P-glycoprotein antagonists
J Biol Chem
An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1. (P-glycoprotein) gene
Cell
Cellular transport of anthracyclines by passive diffusion
Biochem Pharmacol
Is the multidrug transporter a flippase?
Trends Biochem Sci
Cell biological mechanisms of multidrug resistance in tumors
Proc Natl Acad Sci USA
The biochemistry of P-glycoprotein-mediated multidrug resistance
Annu Rev Biochem
Cited by (76)
Sesquiterpenoids and flavonoids from Inula viscosa induce programmed cell death in kinetoplastids
2020, Biomedicine and PharmacotherapyOxazolo[3,2-a]pyridine. A new structural scaffold for the reversal of multi-drug resistance in Leishmania
2012, Bioorganic and Medicinal Chemistry LettersNon-reducing trisaccharide fatty acid monoesters: Novel detergents in membrane biochemistry
2011, Biochimica et Biophysica Acta - BiomembranesThe role of ATP-binding cassette (ABC) proteins in protozoan parasites
2009, Molecular and Biochemical ParasitologyNew terpenoids from Maytenus apurimacensis as MDR reversal agents in the parasite Leishmania
2008, Bioorganic and Medicinal ChemistryInduction of apoptosis-like cell death by pentamidine and doxorubicin through differential inhibition of topoisomerase II in arsenite-resistant L. donovani
2007, Acta TropicaCitation Excerpt :Here we report the differential inhibition of topo II activity in two strains in presence of doxorubicin. An earlier report of daunomycin (a related anthracycline) resistance in L. tropica suggested a multifactorial events involving alteration in drug membrane permeability and the overexpression of P-glycoprotein like drug efflux pump (Chiqueroa et al., 1998). Both membrane extrusion pumps together with alteration in topo II has been implicated in resistance to doxorubicin in different mammalian cancer cell lines (Bader et al., 1998; Kim et al., 1997).